We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.85B
Cap. Flow %
-89.66%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.1 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Miscellaneous 10.26%
5 Real Estate 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XAGEW
401
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$82.8K ﹤0.01%
371,250
– –
2023 Q3
1 quarter
MGM icon
402
PUT
MGM Resorts International
MGM
$7.36B
$82.1K ﹤0.01%
35,000
– –
2023 Q1
3 quarters
TV icon
403
CALL
Televisa
TV
$1.16B
$80.8K ﹤0.01%
+73,500
New +$208K
2023 Q4
0 quarters
BPMC icon
404
CALL
DELISTED
Blueprint Medicines
BPMC
$72K ﹤0.01%
10,000
-15,000
-60% -$972K
2023 Q3
1 quarter
INSM icon
405
CALL
Insmed
INSM
$22B
$71.3K ﹤0.01%
+30,000
New +$778K
2023 Q4
0 quarters
SPY icon
406
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$68K ﹤0.01%
277,500
+167,500
+152% +$74.6M
2019 Q4
16 quarters
CRNX icon
407
CALL
DELISTED
Crinetics Pharmaceuticals
CRNX
$67.5K ﹤0.01%
30,000
-30,000
-50% -$920K
2023 Q3
1 quarter
ROIV icon
408
CALL
Roivant Sciences
ROIV
$25.6B
$62.5K ﹤0.01%
+100,000
New +$975K
2023 Q4
0 quarters
TGTX icon
409
CALL
TG Therapeutics
TGTX
$8.48B
$55K ﹤0.01%
+50,000
New +$581K
2023 Q4
0 quarters
THRX
410
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$50.7K ﹤0.01%
12,517
-168,935
-93% -$515K
2023 Q1
3 quarters
NCLH icon
411
PUT
Norwegian Cruise Line
NCLH
$7.15B
$48.2K ﹤0.01%
55,100
– –
2021 Q2
10 quarters
CZR icon
412
PUT
Caesars Entertainment
CZR
$6.01B
$44.2K ﹤0.01%
15,000
– –
2023 Q3
1 quarter
BIIB icon
413
CALL
Biogen
BIIB
$33.3B
$44K ﹤0.01%
+10,000
New +$2.46M
2023 Q4
0 quarters
ARDX icon
414
CALL
Ardelyx
ARDX
$847M
$37.5K ﹤0.01%
150,000
– –
2023 Q3
1 quarter
WDC icon
415
PUT
Western Digital
WDC
$149B
$35.5K ﹤0.01%
19,184
– –
2023 Q1
3 quarters
BMRN icon
416
CALL
BioMarin Pharmaceuticals
BMRN
$10.6B
$31.2K ﹤0.01%
+43,000
New +$3.8M
2023 Q4
0 quarters
UAL icon
417
PUT
United Airlines
UAL
$34.9B
$30.5K ﹤0.01%
333,900
– –
2021 Q4
8 quarters
RDN icon
418
PUT
Radian Group
RDN
$4.49B
$27.5K ﹤0.01%
50,000
-4,900
-9% -$129K
2021 Q2
10 quarters
GAQ.WS icon
419
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
$26.4K ﹤0.01%
938,800
– –
2023 Q2
2 quarters
XLF icon
420
PUT
State Street Financial Select Sector SPDR ETF
XLF
$50.9B
$24.8K ﹤0.01%
+450,000
New +$15.6M
2023 Q4
0 quarters
CVIIW icon
421
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$23.9K ﹤0.01%
133,530
-60,018
-31% -$9.97K
2021 Q2
10 quarters
SKGRW icon
422
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$23.4K ﹤0.01%
+420,833
New +$23K
2023 Q4
0 quarters
UBER icon
423
PUT
Uber
UBER
$146B
$23.2K ﹤0.01%
+170,000
New +$8.89M
2023 Q4
0 quarters
RCUS icon
424
CALL
Arcus Biosciences
RCUS
$3.11B
$22.8K ﹤0.01%
35,000
– –
2023 Q3
1 quarter
QURE icon
425
CALL
uniQure
QURE
$1.57B
$22.5K ﹤0.01%
90,600
+600
+0.7% +$3.96K
2023 Q2
2 quarters

Similar funds

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.